| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |